About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Sofra™
RNA Vaccines and Therapeutics
Autoimmune Disease
Scientific Background
Chroma™
Clinical Trials
Publications & Events
Investor Centre
Share Price
ASX Announcements
Presentations, Interviews & Media
Annual Reports
Financial Reports
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Presentations, Interviews & Media
Annual Reports
Financial Reports
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
2019
Older
9 Oct 2020
Noxopharm CMO Discusses the NOXCOVID trial
9 Oct 2020
Unlisted Options Expiring 27 November 2020
9 Oct 2020
Cleansing Notice
9 Oct 2020
Appendix 2A
6 Oct 2020
Noxopharm Loan Terms Amended to Benefit Company
2 Oct 2020
First COVID-19 Patient Treated in Veyonda Study
21 Sep 2020
Noxopharm Corporate Presentation September 2020
18 Sep 2020
Noxopharm Appoints US Corporate Advisory and Consulting Firm
17 Sep 2020
Notification of Date of 2020 Annual General Meeting
15 Sep 2020
Annual Report to shareholders
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
